Versant Capital Management »

Silverback Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $30k 2.6k 11.65
2025-09-30 $14k 1.3k 10.05
2025-06-30 $11k 622 17.45
2025-03-31 $7.8k 622 12.58

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Vaneck Gold Miners Etf Etf (GDX)
Microsoft Stock (MSFT)
Ishares S&p Global Energy Etf (IXC)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)

View all positions for Versant Capital Management

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Deerfield Management Company
BlackRock
Rubric Capital Management
Sr One Capital Management
Standard Life Aberdeen
Vanguard Group
State Street Corporation
Alliancebernstein
Franklin Resources
Citadel Advisors
Casdin Capital
Geode Capital Management
Southpoint Capital Advisors

View all funds holding Silverback Therapeutics